| Name | 5-bromo-2-tert-butylpyridine |
|---|---|
| Synonyms |
5-Brom-2-tert.-butylpyridin
Pyridine, 5-bromo-2-(1,1-dimethylethyl)- 5-Bromo-2-(2-methyl-2-propanyl)pyridine |
| Density | 1.3±0.1 g/cm3 |
|---|---|
| Boiling Point | 230.0±20.0 °C at 760 mmHg |
| Molecular Formula | C9H12BrN |
| Molecular Weight | 214.102 |
| Flash Point | 92.9±21.8 °C |
| Exact Mass | 213.015305 |
| PSA | 12.89000 |
| LogP | 3.44 |
| Vapour Pressure | 0.1±0.4 mmHg at 25°C |
| Index of Refraction | 1.521 |
| Hazard Codes | Xi |
|---|---|
| HS Code | 2933399090 |
|
~51%
39919-58-9 |
| Literature: Pfizer, Inc. Patent: US2006/211741 A1, 2006 ; Location in patent: Page/Page column 61 ; |
| Precursor 1 | |
|---|---|
| DownStream 0 | |
| HS Code | 2933399090 |
|---|---|
| Summary | 2933399090. other compounds containing an unfused pyridine ring (whether or not hydrogenated) in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |